1119 related articles for article (PubMed ID: 23811251)
1. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
[TBL] [Abstract][Full Text] [Related]
2. Discriminant value of serum HBV DNA levels as predictors of liver fibrosis in chronic hepatitis B.
Sanai FM; Helmy A; Bzeizi KI; Babatin MA; Al-Qahtani A; Al-Ashgar HA; Al-Mdani AS; Al-Akwaa A; Almutharea S; Khan MQ; Alghamdi AS; Farah T; Al-Hamoudi W; Saadeh M; Abdo AA
J Viral Hepat; 2011 Jul; 18(7):e217-25. PubMed ID: 21692936
[TBL] [Abstract][Full Text] [Related]
3. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
Li Q; Li W; Huang Y; Chen L
J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
[TBL] [Abstract][Full Text] [Related]
4. Histologic evidence of active liver injury in chronic hepatitis B patients with normal range or minimally elevated alanine aminotransferase levels.
Hu KQ; Schiff ER; Kowdley KV; Min AD; Shiffman ML; Lee WM; Goodman ZD; Dau LO; Peschell KJ; Fagan EA; Flaherty JF
J Clin Gastroenterol; 2010 Aug; 44(7):510-6. PubMed ID: 20179614
[TBL] [Abstract][Full Text] [Related]
5. Decreasing hepatitis B viral load is associated with a risk of significant liver fibrosis in hepatitis B e antigen positive chronic hepatitis B.
Xie Q; Hu X; Zhang Y; Jiang X; Li X; Li J
J Med Virol; 2014 Nov; 86(11):1828-37. PubMed ID: 25145769
[TBL] [Abstract][Full Text] [Related]
6. Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients.
Wong GL; Wong VW; Choi PC; Chan AW; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL
Clin Gastroenterol Hepatol; 2009 Feb; 7(2):227-33. PubMed ID: 19121647
[TBL] [Abstract][Full Text] [Related]
7. HBV DNA level could predict significant liver fibrosis in HBeAg negative chronic hepatitis B patients with biopsy indication.
Praneenararat S; Chamroonkul N; Sripongpun P; Kanngurn S; Jarumanokul R; Piratvisuth T
BMC Gastroenterol; 2014 Dec; 14():218. PubMed ID: 25523185
[TBL] [Abstract][Full Text] [Related]
8. Significant hepatic histopathology in chronic hepatitis B patients with serum ALT less than twice ULN and high HBV-DNA levels in Indonesia.
Lesmana CR; Gani RA; Hasan I; Simadibrata M; Sulaiman AS; Pakasi LS; Budihusodo U; Krisnuhoni E; Lesmana LA
J Dig Dis; 2011 Dec; 12(6):476-80. PubMed ID: 22118698
[TBL] [Abstract][Full Text] [Related]
9. Off-therapy durability of response to entecavir therapy in hepatitis B e antigen-negative chronic hepatitis B patients.
Jeng WJ; Sheen IS; Chen YC; Hsu CW; Chien RN; Chu CM; Liaw YF
Hepatology; 2013 Dec; 58(6):1888-96. PubMed ID: 23744454
[TBL] [Abstract][Full Text] [Related]
10. [Accuracy of FibroScan for the diagnosis of liver fibrosis influenced by serum alanine aminotransferase levels in patients with chronic hepatitis B].
Chen XB; Zhu X; Chen LY; Chen EQ; Tang H
Zhonghua Gan Zang Bing Za Zhi; 2011 Apr; 19(4):286-90. PubMed ID: 21586228
[TBL] [Abstract][Full Text] [Related]
11. A model to predict antiviral treatment in HBeAg negative chronic hepatitis B with alanine aminotransferase≤2 upper limit of normal.
Gao S; Fan YC; Zhao J; Sun FK; Han J; Zhao ZH; Wang K
Liver Int; 2014 Aug; 34(7):e229-37. PubMed ID: 24112455
[TBL] [Abstract][Full Text] [Related]
12. Liver histopathological lesions is severe in patients with normal alanine transaminase and low to moderate hepatitis B virus DNA replication.
Jiang SW; Lian X; Hu AR; Lu JL; He ZY; Shi XJ; Zhu DD; Wang ZY; Huang GC
World J Gastroenterol; 2023 Apr; 29(16):2479-2494. PubMed ID: 37179582
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of normal or minimally elevated alanine transaminase, age and DNA level in predicting liver histological changes in chronic hepatitis B.
Alam S; Ahmad N; Mustafa G; Shrestha A; Alam AK; Khan M
Liver Int; 2011 Jul; 31(6):824-30. PubMed ID: 21645213
[TBL] [Abstract][Full Text] [Related]
14. Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.
Martinot-Peignoux M; Lapalus M; Laouénan C; Lada O; Netto-Cardoso AC; Boyer N; Ripault MP; Carvalho-Filho R; Asselah T; Marcellin P
J Clin Virol; 2013 Oct; 58(2):401-7. PubMed ID: 24004660
[TBL] [Abstract][Full Text] [Related]
15. Liver fibrosis progression is uncommon in patients with inactive chronic hepatitis B: a prospective cohort study with paired transient elastography examination.
Wong GL; Chan HL; Yu Z; Chan HY; Tse CH; Wong VW
J Gastroenterol Hepatol; 2013 Dec; 28(12):1842-8. PubMed ID: 23829381
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage.
Wu IC; Lai CL; Han SH; Han KH; Gordon SC; Chao YC; Tan CK; Sievert W; Tanwandee T; Xu D; Neo BL; Chang TT
Hepatology; 2010 Apr; 51(4):1185-9. PubMed ID: 20044806
[TBL] [Abstract][Full Text] [Related]
17. [Characteristic of liver pathology in HBeAg-positive and HBeAg-negative chronic hepatitis B patients with mildly elevated ALT].
Liu SQ; Zhu XJ; Sun XH; Li M; Gao YQ
Zhonghua Gan Zang Bing Za Zhi; 2012 May; 20(5):348-52. PubMed ID: 22971279
[TBL] [Abstract][Full Text] [Related]
18. A survey of chronic hepatitis B patient management practices in the European Union.
Berg T; Benhamou Y; Calleja JL; Levrero M; Johnson W; Ellis N
J Viral Hepat; 2010 Sep; 17(9):624-30. PubMed ID: 20487257
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous increases in alanine aminotransferase levels in asymptomatic chronic hepatitis B virus-infected patients.
Kumar M; Chauhan R; Gupta N; Hissar S; Sakhuja P; Sarin SK
Gastroenterology; 2009 Apr; 136(4):1272-80. PubMed ID: 19208347
[TBL] [Abstract][Full Text] [Related]
20. Updated thresholds for alanine aminotransferase do not exclude significant histological disease in chronic hepatitis C.
Sanai FM; Helmy A; Dale C; Al-Ashgar H; Abdo AA; Katada K; AlMana H; Saadeh M; Al-Hussaini H; AlQuaiz M; Hashem A; AlSwat K; Bzeizi KI; Marotta PJ
Liver Int; 2011 Aug; 31(7):1039-46. PubMed ID: 21733094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
